Stroke therapy in patients considering prothrombin time and international normalized ratio.
Albright
Karen
K
Stemer
Andrew
A
Tafreshi
Gilda
G
Hemmen
Thomas
T
D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use*; D002545:Brain Ischemia / Q000150:complications; D004632:Emergency Medical Services; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D019934:International Normalized Ratio; D011517:Prothrombin Time; D020521:Stroke / Q000175:diagnosis* / Q000209:etiology / Q000378:metabolism* / Q000628:therapy*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator